Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Dr. Martens plc (3U2.F)

0.5900
+0.0050
+(0.85%)
At close: 8:07:41 AM GMT+2
Loading Chart for 3U2.F
  • Previous Close 0.5850
  • Open 0.5900
  • Bid 0.5750 x --
  • Ask 0.6650 x --
  • Day's Range 0.5900 - 0.5900
  • 52 Week Range 0.4940 - 1.0500
  • Volume 35,800
  • Avg. Volume 952
  • Market Cap (intraday) 596.077M
  • Beta (5Y Monthly) 0.07
  • PE Ratio (TTM) 19.67
  • EPS (TTM) 0.0300
  • Earnings Date Jun 5, 2025
  • Forward Dividend & Yield 0.02 (3.72%)
  • Ex-Dividend Date Mar 6, 2025
  • 1y Target Est --

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company was founded in 1945 and is based in London, the United Kingdom.

www.drmartensplc.com

2,630

Full Time Employees

March 31

Fiscal Year Ends

Recent News: 3U2.F

View More

Performance Overview: 3U2.F

Trailing total returns as of 4/23/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

3U2.F
28.15%
FTSE 100 (^FTSE)
2.82%

1-Year Return

3U2.F
24.09%
FTSE 100 (^FTSE)
4.45%

3-Year Return

3U2.F
76.33%
FTSE 100 (^FTSE)
11.72%

5-Year Return

3U2.F
89.07%
FTSE 100 (^FTSE)
44.22%

Compare To: 3U2.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 3U2.F

View More

Valuation Measures

Annual
As of 4/22/2025
  • Market Cap

    588.19M

  • Enterprise Value

    1.00B

  • Trailing P/E

    17.36

  • Forward P/E

    10.36

  • PEG Ratio (5yr expected)

    5.18

  • Price/Sales (ttm)

    0.60

  • Price/Book (mrq)

    1.45

  • Enterprise Value/Revenue

    1.07

  • Enterprise Value/EBITDA

    6.10

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.65%

  • Return on Assets (ttm)

    4.53%

  • Return on Equity (ttm)

    8.42%

  • Revenue (ttm)

    805.9M

  • Net Income Avi to Common (ttm)

    29.4M

  • Diluted EPS (ttm)

    0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    94.9M

  • Total Debt/Equity (mrq)

    134.44%

  • Levered Free Cash Flow (ttm)

    189.08M

Research Analysis: 3U2.F

View More

Company Insights: 3U2.F

Research Reports: 3U2.F

View More

People Also Watch